<qa>  What is the name of the Phase 3 Study to Evaluate the Efficacy and SafetyA Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid dependent Asthma. 